Procurement of 150 kg of the active substance BTZ-043

Auto-translated from German

Original title: Beschaffung von 150 kg des Wirkstoffs BTZ-043

LMU Klinikum (Klinikum der Ludwig-Maximilians-Universität München)

Published: Aug 3, 2026

Updated: Aug 9, 2026

Source: oeffentlichevergabe_de

This tender has been awarded

Awarded to HAPILA GmbH

Browse open Health & Medical tenders in Germany

About This Opportunity

This is a supplies contract in the health and medical services, legal services and trade and industry sectors, with a focus on Intellectual Property and Manufacturing. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through DÖE Bekanntmachungsservice (Germany), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from German

The subject of the procurement is the GMP-compliant manufacture of 150 kg of the active substance BTZ-043 for clinical Phase III approval studies. Due to existing patents, exclusive manufacturing rights, and the proprietary manufacturing process fully optimized according to Quality by Design (QbD) and GMP-certified, HAPILA GmbH is the only economic operator capable of producing the active substance in the quality required for clinical studies and subsequent approval, comparable to previous batches. Other licensees are exclusively authorized to produce research chemicals and are not permitted to produce BTZ-043 as an active pharmaceutical ingredient.

Data provenance

This notice is sourced from DÖE Bekanntmachungsservice (Germany) and was originally published on August 3, 2026. Last refreshed 3 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About LMU Klinikum (Klinikum der Ludwig-Maximilians-Universität München)

LMU Klinikum (Klinikum der Ludwig-Maximilians-Universität München) has issued 9 procurement notices on BidsFactory, including 0 currently open and 9 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and Private Sector. All notices are published for Germany. Notices are distributed via DÖE Bekanntmachungsservice (Germany) and TED - Tenders Electronic Daily (EU). Most recent publication: August 3, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit DÖE Bekanntmachungsservice (Germany) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to HAPILA GmbH. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by LMU Klinikum (Klinikum der Ludwig-Maximilians-Universität München) in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.